Cargando…

The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review

BACKGROUND: Lower respiratory tract infections (LRTI) are a major cause of morbidity and mortality worldwide, particularly in young children and older adults. Influenza is known to cause severe disease but the risk of developing LRTI following influenza virus infection in various populations has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Malosh, Ryan E., Martin, Emily T., Ortiz, Justin R., Monto, Arnold S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736984/
https://www.ncbi.nlm.nih.gov/pubmed/29157959
http://dx.doi.org/10.1016/j.vaccine.2017.11.018
_version_ 1783287457234550784
author Malosh, Ryan E.
Martin, Emily T.
Ortiz, Justin R.
Monto, Arnold S.
author_facet Malosh, Ryan E.
Martin, Emily T.
Ortiz, Justin R.
Monto, Arnold S.
author_sort Malosh, Ryan E.
collection PubMed
description BACKGROUND: Lower respiratory tract infections (LRTI) are a major cause of morbidity and mortality worldwide, particularly in young children and older adults. Influenza is known to cause severe disease but the risk of developing LRTI following influenza virus infection in various populations has not been systematically reviewed. Such data are important for estimating the impact specific influenza vaccine programs would have on LRTI outcomes in a community. We sought to review the published literature to determine the risk of developing LRTI following an influenza virus infection in individuals of any age. METHODS AND FINDINGS: We conducted a systematic review to identify prospective studies that estimated the incidence of LRTI following laboratory-confirmed influenza virus infection. We searched PubMed, Medline, and Embase databases for relevant literature. We supplemented this search with a narrative review of influenza and LRTI. The systematic review identified two prospective studies that both followed children less than 5 years. We also identified one additional pediatric study from our narrative review meeting the study inclusion criteria. Finally, we summarized recent case-control studies on the etiology of pneumonia in both adults and children. CONCLUSIONS: There is a dearth of prospective studies evaluating the risk of developing LRTI following influenza virus infection. Determining the burden of severe LRTI that is attributable to influenza is necessary to estimate the benefits of influenza vaccine on this important public health outcome. Vaccine probe studies are an efficient way to evaluate these questions and should be encouraged going forward.
format Online
Article
Text
id pubmed-5736984
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-57369842018-01-02 The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review Malosh, Ryan E. Martin, Emily T. Ortiz, Justin R. Monto, Arnold S. Vaccine Article BACKGROUND: Lower respiratory tract infections (LRTI) are a major cause of morbidity and mortality worldwide, particularly in young children and older adults. Influenza is known to cause severe disease but the risk of developing LRTI following influenza virus infection in various populations has not been systematically reviewed. Such data are important for estimating the impact specific influenza vaccine programs would have on LRTI outcomes in a community. We sought to review the published literature to determine the risk of developing LRTI following an influenza virus infection in individuals of any age. METHODS AND FINDINGS: We conducted a systematic review to identify prospective studies that estimated the incidence of LRTI following laboratory-confirmed influenza virus infection. We searched PubMed, Medline, and Embase databases for relevant literature. We supplemented this search with a narrative review of influenza and LRTI. The systematic review identified two prospective studies that both followed children less than 5 years. We also identified one additional pediatric study from our narrative review meeting the study inclusion criteria. Finally, we summarized recent case-control studies on the etiology of pneumonia in both adults and children. CONCLUSIONS: There is a dearth of prospective studies evaluating the risk of developing LRTI following influenza virus infection. Determining the burden of severe LRTI that is attributable to influenza is necessary to estimate the benefits of influenza vaccine on this important public health outcome. Vaccine probe studies are an efficient way to evaluate these questions and should be encouraged going forward. Elsevier Science 2018-01-02 /pmc/articles/PMC5736984/ /pubmed/29157959 http://dx.doi.org/10.1016/j.vaccine.2017.11.018 Text en © 2017 World Health Organization. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Malosh, Ryan E.
Martin, Emily T.
Ortiz, Justin R.
Monto, Arnold S.
The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review
title The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review
title_full The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review
title_fullStr The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review
title_full_unstemmed The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review
title_short The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review
title_sort risk of lower respiratory tract infection following influenza virus infection: a systematic and narrative review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736984/
https://www.ncbi.nlm.nih.gov/pubmed/29157959
http://dx.doi.org/10.1016/j.vaccine.2017.11.018
work_keys_str_mv AT maloshryane theriskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview
AT martinemilyt theriskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview
AT ortizjustinr theriskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview
AT montoarnolds theriskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview
AT maloshryane riskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview
AT martinemilyt riskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview
AT ortizjustinr riskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview
AT montoarnolds riskoflowerrespiratorytractinfectionfollowinginfluenzavirusinfectionasystematicandnarrativereview